Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Solid Neoplasms × Fluorouracil × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 24 Pancreatic Neoplasms 15 Stomach Neoplasms 12 Rectal Neoplasms 10 Colonic Neoplasms 10 Esophageal Neoplasms 9 Adenocarcinoma Of Esophagus 8 Neoplasms 7 Urinary Bladder Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Carcinoma, Non-Small-Cell Lung 5 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Cholangiocarcinoma 4 Breast Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Gastrointestinal Neoplasms 3 Anus Neoplasms 3 Adenocarcinoma 3 Nasopharyngeal Carcinoma 2 Melanoma 2 Lung Neoplasms 2 Hepatoblastoma 2 Gallbladder Neoplasms 2 Clinical Stage I Gastric Cancer AJCC v8 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urothelial Carcinoma of the Bladder 1

Interventions

pembrolizumab 1 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04420884 2025-06-13

iintune-1

Takeda

Phase 1/2 Active not recruiting

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡